Biotech Showcase 2015 EBD Group Demy Colton Life Science Advisors Biotech Showcase 2015
Email this page Share this on LinkedIn Share this on Twitter

Biotech Showcase™ 2015 Press Releases

News for Biotech Showcase™ 2015 will be available soon.

Biotech Showcase 2014 press releases

January 23, 2014Unprecedented Biotech Showcase™ 2014 attendance reflects investor appetite for biotech innovationOver 1,700 delegates attend investor conference in San Francisco
The sixth annual Biotech Showcase investor conference wrapped up last week in San Francisco with record attendance. The event, every January at Parc 55 Wyndham San Francisco - Union Square, is an investment weathervane for the biotech industry. "There was clearly significant momentum behind the conference this year. The event benefited from the up market for life sciences c...  more ►

January 9, 2014Biotech Investing Strategies in 2014 is key topic bringing investors to San Francisco for Biotech Showcase™ 2014 next week, January 13 Innovative presenting companies comprising early stage and biotech are on the program for the sixth annual Biotech Showcase investor and partnering conference taking place in San Francisco next week. The event, held January 13–15 at Parc 55 Wyndham San Francisco - Union Square, already has 963 companies and 1,480 delegates attending, providing a forum for investors to ca...  more ►

December 18, 2013Biotech Showcase™ program speakers have their fingers on the pulse of biotech Biotech Showcase investor and partnering conference returns to San Francisco for the sixth year. This established innovation showcase for life science investors will be held January 13–15, 2014 at Parc 55 Wyndham San Francisco - Union Square. The event draws executives representing top public and private biotech and life science companies and investors seeking new opport...  more ►

November 21, 2013Sixth Annual Biotech Showcase™ returns to San Francisco January 13–15Event is annual investing and partnering benchmark for life science executives and investors
The sixth annual Biotech Showcase investor and partnering conference will be held January 13–15, 2014 in San Francisco, CA at Parc 55 Wyndham San Francisco - Union Square. The event is an established innovation showcase for life science investors. Executive-level delegates representing top public and private investment firms come with the single aim to partner with emerg...  more ►

partnering360® Blog

October 30, 2014 Who can you meet with next week at BIO-Europe®? BIO-Europe® is quickly approaching.  Next week, the life science partnering community will meet in Frankfurt.  Gain insights from keynote speakers including Andreas Busch, Member, Executive Committee, Head, Global Drug Discovery at Bayer HealthCare; David Loew, Senior VP Commercial Operations,... more ►

October 28, 2014 Shifting models in life science partnering Ahead of BIO-Europe®, Susan Herbert, Executive VP for Global Business Development and Alliance Management at Merck Serono, sat down with our Insight team to discuss the new, evolving landscape that is partnering in the industry. Shifts include better communication and working with companies that... more ►

October 24, 2014 Insight into Antigen Express’ immunotherapy Antigen Express is a company who uses their technology to promote immunotherapy to fight many cancers and develop vaccines so that the human body can defend itself. According to a recent article at Insight, their patented peptides are critical in developing immune responses. How does this therapy... more ►

October 23, 2014 Why did only a few European biotechs make it through the IPO window? Guest post from Steve Dickman, CEO, CBT Advisors. Originally posted to Boston Biotech Watch. If the recent falloff in biotech IPOs continues, then many European biotechs would seem to have missed the longest, widest IPO window in the history of the industry. Why did a few European biotechs manage... more ►

October 21, 2014 News from around BIO-Europe® With BIO-Europe just weeks away, many companies are have moved various products along the pipeline and many are seeing success in developing and moving drugs through pipelines: - Apricus Biosciences recently announced that Notice of Allowance for they have received U.S. Patent Application Serial... more ►

partnering360:Insight Latest headlines from partnering360:Insight

October 20, 2014 Merck Serono: FIT for partnering and playing with the home court advantage "We are interested in opportunities—spanning from promising drug candidates up to technology platforms—that will support our strategic business objectives, and strengthen our pipeline, our key franchises, and our geographic presence." more ►

October 17, 2014 Antigen Express advances immunotherapy Antigen Express is developing a novel way to boost the immune system, developing a therapeutic platform that can produce off-the-shelf, synthetic peptide vaccines for major diseases, including cancer, HIV, influenza, diabetes and, potentially, Ebola. more ►

October 17, 2014 Third Rock Ventures sees “renaissance of innovation in life sciences” A co-founder of Third Rock Ventures, Kevin Starr focuses on the development and business strategy of the portfolio companies, actively identifying and evaluating new investments. In March, 2013 the firm raised USD 516 million for its Fund III. Several new companies have since been launched and Starr said a further 14 companies will be formed, "most of which are already under consideration inside Third Rock, though we have not announced anything to the outside world yet." more ►

October 13, 2014 Accelerating drug discovery in Singapore creates global successes Building on a string of recent successes, a team from Singapore's Experimental Therapeutics Centre (ETC) arrives in Frankfurt for BIO-Europe® 2014 looking for new opportunities in early stage co-discovery projects. more ►

October 11, 2014 Customized bio-IT solutions are not just for big pharma anymore BIO-Europe® 2014 in Frankfurt will see the soft launch for a bundled product-and-service called the MediSapiens Explorer Platform that brings to small and medium-sized biotechs and pharma companies a platform for managing and accessing massive data sets, and the tools to visualize it in scientist-friendly way. more ►

Arrow Up

See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2014 EBD Group, Inc.
Privacy Policy
Terms of Use
Biotech Showcase 2015 EBD Group Demy Colton Life Science Advisors Biotech Showcase 2015